John Paul Mounsey
Role not yet determined Is this you? Add your title
Also affiliated: Rutgers, The State University of New Jersey (2021); University of North Carolina at Chapel Hill (2007–2025); University of North Texas (2006); United States Department of Veterans Affairs (2021); St Thomas' Hospital (1983–1987); University of North Carolina Health Care (2012–2015); University of Arizona (2021); East Carolina University (2017–2021); University of Arkansas Medical Center (2021–2023); University of Virginia Health System (1995–2009); Freeman Hospital (1994); Yale University (2021); University of Virginia Hospital (2001); University of North Carolina Hospitals (2015–2018); University of Virginia Medical Center (1995–2004); University of Virginia (1995–2009); University of Birmingham (1995)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
John Paul Mounsey's research centers on cardiovascular conditions, particularly arrhythmias and the outcomes of interventions. He has investigated cerebrovascular complications associated with pulmonary vein ablation and explored hybrid epicardial-endocardial ablation techniques for atrial fibrillation. His work also includes studying the epidemiology, management, and outcomes of sustained ventricular arrhythmias in patients with left ventricular assist devices, as well as the coexistence of different types of tachycardia in patients with surgically corrected congenital heart disease.
Mounsey has also examined the predictive value of myocardial viability for biventricular pacing response in ischemic cardiomyopathy. His research extends to pharmacological interventions, as evidenced by his systematic review and meta-analysis of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes. He has a substantial publication record, with 167 total publications and a citation count of 3,264, reflected in an h-index of 34, designating him as a highly cited researcher. He actively leads a research group and maintains a lab website, collaborating with colleagues at the University of Arkansas for Medical Sciences, including Subodh Devabhaktuni, Hakan Paydak, and Srikanth Vallurupalli.
Metrics
- h-index: 34
- Publications: 169
- Citations: 3,257
Selected Publications
-
Dual-morphology Bundle Branch Re-entrant Ventricular Tachycardia in Non-dilated Cardiomyopathy (2025)
-
Percutaneous pericardiocentesis using the apical approach: case series and review of the literature (2024)
-
Inappropriate Subcutaneous Implantable Cardioverter-defibrillator Shocks—A Rare Case of Triple Counting (2023)
-
Correction to: Primary prevention programming for defibrillators: need for a device clinic-based intervention (2023)
-
How should we measure success in atrial fibrillation ablation? The monitoring strategy depends on the outcome of interest (2023)
-
Primary prevention programming for defibrillators: need for a device clinic-based intervention (2023)
-
WAVELET DECOMPOSITION USING FAST FOURIER TRANSFORMFOR THE PREDICTION OF INCIDENT ATRIAL FIBRILLATION ON ELECTROCARDIOGRAPHY (2023)
-
Promises and challenges of machine learning for device therapy in heart failure (2023)
-
Abstract 15427: Reduction of Epicardial Fat, Clinical Risk Factors & Symptomatology in Paroxysmal AF Patient With Severe Aortic Stenosis and Metabolic Syndrome via Mobile Cardiometabolic Health & Weight Loss Program (2022)
-
Meta-Analysis Comparing Anterior-Lateral Versus Anterior-Posterior Electrode Position for Biphasic Cardioversion in Atrial Fibrillation (2022)
-
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis (2022)
-
Improved Ablation Efficiency in PVI Guided by Contact Force and Local Impedance: Chronic Canine Model (2022)
-
Is heart rate in post-hematopoietic stem cell transplant patients clinically relevant? (2021)
-
Out of Hospital Sudden Death in a Rural Population: Low Rates of ICD Underutilization Among Decedents (2021)
-
Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update (2020)
Collaboration Network
Top Collaborators
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- Meta-Analysis Comparing Anterior-Lateral Versus Anterior-Posterior Electrode Position for Biphasic Cardioversion in Atrial Fibrillation
- Percutaneous pericardiocentesis using the apical approach: case series and review of the literature
Showing 5 of 7 shared publications
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- Promises and challenges of machine learning for device therapy in heart failure
- Percutaneous pericardiocentesis using the apical approach: case series and review of the literature
Showing 5 of 6 shared publications
- Meta-Analysis Comparing Anterior-Lateral Versus Anterior-Posterior Electrode Position for Biphasic Cardioversion in Atrial Fibrillation
- Percutaneous pericardiocentesis using the apical approach: case series and review of the literature
- WAVELET DECOMPOSITION USING FAST FOURIER TRANSFORMFOR THE PREDICTION OF INCIDENT ATRIAL FIBRILLATION ON ELECTROCARDIOGRAPHY
- Abstract 15427: Reduction of Epicardial Fat, Clinical Risk Factors & Symptomatology in Paroxysmal AF Patient With Severe Aortic Stenosis and Metabolic Syndrome via Mobile Cardiometabolic Health & Weight Loss Program
- Inappropriate Subcutaneous Implantable Cardioverter-defibrillator Shocks—A Rare Case of Triple Counting
Showing 5 of 6 shared publications
- Meta-Analysis Comparing Anterior-Lateral Versus Anterior-Posterior Electrode Position for Biphasic Cardioversion in Atrial Fibrillation
- WAVELET DECOMPOSITION USING FAST FOURIER TRANSFORMFOR THE PREDICTION OF INCIDENT ATRIAL FIBRILLATION ON ELECTROCARDIOGRAPHY
- Abstract 15427: Reduction of Epicardial Fat, Clinical Risk Factors & Symptomatology in Paroxysmal AF Patient With Severe Aortic Stenosis and Metabolic Syndrome via Mobile Cardiometabolic Health & Weight Loss Program
- Inappropriate Subcutaneous Implantable Cardioverter-defibrillator Shocks—A Rare Case of Triple Counting
- Dual-morphology Bundle Branch Re-entrant Ventricular Tachycardia in Non-dilated Cardiomyopathy
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- Meta-Analysis Comparing Anterior-Lateral Versus Anterior-Posterior Electrode Position for Biphasic Cardioversion in Atrial Fibrillation
- Program Planning in Education and Light Exercise Training for Atrial Fibrillation Patients
- Out of Hospital Sudden Death in a Rural Population: Low Rates of ICD Underutilization Among Decedents
- Out of Hospital Sudden Death in a Rural Population: Low Rates of ICD Underutilization Among Decedents
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
- COVID-19: an unprecedented pandemia with a potential arrhythmic undertone
- Is heart rate in post-hematopoietic stem cell transplant patients clinically relevant?
- Out of Hospital Sudden Death in a Rural Population: Low Rates of ICD Underutilization Among Decedents
- Out of Hospital Sudden Death in a Rural Population: Low Rates of ICD Underutilization Among Decedents
Similar Researchers
Based on overlapping research topics